Publication: Long‐term stroke risk prediction in patients with atrial fibrillation: comparison of the ABC‐stroke and CHA2DS2‐VASc scores
| dc.contributor.author | Rivera Caravaca, José Miguel | |
| dc.contributor.author | Roldán Schilling, Vanessa | |
| dc.contributor.author | Esteve-Pastor, María Asunción | |
| dc.contributor.author | Valdés Chávarri, Mariano | |
| dc.contributor.author | Vicente García, Vicente | |
| dc.contributor.author | Lip, Gregory YH | |
| dc.contributor.author | Marín Ortuño, Francisco | |
| dc.contributor.department | Enfermería | |
| dc.date.accessioned | 2024-02-07T09:51:13Z | |
| dc.date.available | 2024-02-07T09:51:13Z | |
| dc.date.issued | 2017 | |
| dc.description | ª 2017 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. | |
| dc.description.abstract | Background: The ABC-stroke score (age, biomarkers [N-terminal fragment B-type natriuretic peptide, high-sensitivity troponin],and clinical history [prior stroke/transient ischemic attack]) was proposed to predict stroke in atrial fibrillation (AF). This score was derived/validated in 2 clinical trial cohorts in which patients with AF were highly selected and carefully followed-up. However, the median follow-up was 1.9 years in the trial cohort; therefore, its long-term predictive performance remains uncertain. This study aimed to compare the long-term predictive performances of the ABC-stroke and CHA2DS2-VASc (cardiac failure or dysfunction, hypertension, age≥75 [doubled], diabetes mellitus, stroke [doubled]—vascular disease, age 65 to 74 years and sex category[female]) scores in a cohort of anticoagulated patients with AF. Methods and Results: We recruited 1125 consecutive patients with AF who were stable on vitamin K antagonists and followed-up for a median of 6.5 years. ABC-stroke and CHA2DS2-VASc (cardiac failure or dysfunction, hypertension, age≥75 [doubled], diabetes mellitus, stroke [doubled]—vascular disease, age 65 to 74 years and sex category [female]) scores were calculated and compared. Median CHA2DS2-VASc and ABC-stroke scores were 4 (interquartile range 3–5) and 9.1 (interquartile range 7.3–11.3), respectively. There were 114 ischemic strokes (1.55% per year) at 6.5 years. The C-index of ABC-stroke at 3.5 years was significantly higher than CHA2DS2-VASc (0.663 versus 0.600, P=0.046), but both C-indexes were nonsignificantly different at 6.5 years. Integrated discrimination improvement showed a small improvement (<2%) in sensitivity at 3.5 and 6.5 years with ABC-stroke. For ABC-stroke, net reclassification improvement was nonsignificantly different at 3.5 years, and showed a negative reclassification at 6.5 years compared with CHA2DS2-VASc. Decision curve analyses did not show a marked improvement in clinical usefulness of the ABC-stroke score over the CHA2DS2-VASc score. Conclusions: In anticoagulated patients with AF followed-up over a long-term period, the novel ABC-stroke score does not offer significantly better predictive performance compared with the CHA2DS2-VASc score. | es |
| dc.format | application/pdf | es |
| dc.format.extent | 14 | es |
| dc.identifier.citation | Journal of the American Heart Association. 2017 6:e006490 | |
| dc.identifier.doi | https://doi.org/10.1161/JAHA.117.006490 | |
| dc.identifier.issn | Electronic: 2047-9980 | |
| dc.identifier.uri | http://hdl.handle.net/10201/138865 | |
| dc.language | eng | es |
| dc.publisher | Wiley Open Access | |
| dc.publisher | American Heart Association | |
| dc.relation | Instituto de Salud Carlos III (ISCIII) (PI13/00513 y P14/00253), Fundación Séneca (19245/PI/14), RD12/0042/0050, e Instituto Murciano de Investigación Biosanitaria (IMIB16/AP/01/06) | es |
| dc.rights | info:eu-repo/semantics/openAccess | es |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
| dc.subject | Anticoagulantes | es |
| dc.subject | Fibrilación auricular | es |
| dc.subject | Biomarcadores | es |
| dc.subject | Predicción del riesgo | es |
| dc.subject | Ictus | es |
| dc.subject.other | CDU::6 - Ciencias aplicadas::61 - Medicina | es |
| dc.title | Long‐term stroke risk prediction in patients with atrial fibrillation: comparison of the ABC‐stroke and CHA2DS2‐VASc scores | es |
| dc.type | info:eu-repo/semantics/article | es |
| dspace.entity.type | Publication | es |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- rivera-caravaca-et-al-2017-long-term-stroke-risk-prediction-in-patients-with-atrial-fibrillation-comparison-of-the-abc.pdf
- Size:
- 705.15 KB
- Format:
- Adobe Portable Document Format
- Description:
License bundle
1 - 1 of 1
Loading...
- Name:
- license.txt
- Size:
- 2.26 KB
- Format:
- Item-specific license agreed upon to submission
- Description:
Collections
Este ítem está sujeto a una licencia Creative Commons. http://creativecommons.org/licenses/by-nc-nd/4.0/